LinkedIn Image

Evolution of the Treatment Algorithm for Carcinoid Syndrome

Meeting Overview

We are pleased to invite you to our satellite symposium, Evolution of the Treatment Algorithm for Carcinoid Syndrome, to be held on January 19, 2017, in San Francisco, California.


7.15 PM Registration and dinner
7.30 PM Welcome and faculty introduction
Matthew H. Kulke, MD
7.32 PM Test your knowledge in functional gastrointestinal neuroendocrine tumors (GI NETs)
Matthew H. Kulke, MD
7.40 PM GI NETs: The size of the problem
Matthew H. Kulke, MD
7.50 PM The current treatment paradigm for GI NETs
Marianne Pavel, MD
8.15 PM On the horizon: Exploiting biology to treat carcinoid syndrome
Thomas O’Dorisio, MD
8.35 PM Faculty discussion and audience questions
8.45 PM Interactive cases in carcinoid syndrome
Emily K. Bergsland, MD
9.05 PM Knowledge review
Matthew H. Kulke, MD
9.10 PM Concluding remarks and prIME Points™
Matthew H. Kulke, MD
9.15 PM Adjourn


  • Matthew H. Kulke, MDDana-Farber Cancer Institute
    Boston, Massachusetts, United States
  • Emily K. Bergsland, MDUniversity of California, San Francisco
    San Francisco, California, United States
  • Thomas O’Dorisio, MDUniversity of Iowa
    Iowa City, Iowa, United States
  • Marianne Pavel, MDUniversity Hospital Erlangen
    Erlangen, Germany

Target Audience

This educational activity is designed for medical oncologists, endocrinologists, gastroenterologists, surgical oncologists, pathologists, and other healthcare providers as well as patient advocates involved and/or interested in the management of patients with GI NETs.

Learning Objectives

Upon completion of this educational activity, participants should be able to:

  • Describe the clinical characteristics of GI NETs and the most appropriate investigations to stage and plan treatment
  • Assess the current treatment options for carcinoid syndrome management
  • Evaluate the available therapeutic options and identify the optimum sequence of treatments for carcinoid syndrome
Register Now

There is no fee for this activity and preregistration is not required; however, space is limited. Dinner will be served.

Date and Location

Thursday, January 19, 2017
7.15 PM – 9.15 PM

Yerba Buena Ballroom-Salon 7
Marriott Marquis
780 Mission Street
San Francisco, California


This activity is provided by prIME Oncology.

Continuing Education

prIME Oncology is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.


prIME Oncology designates this live activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This educational activity is supported by a grant from Lexicon Pharmaceuticals, Inc.

Sunshine Act and EFPIA Disclosure Code

prIME Oncology complies with all Sunshine Act reporting requirements as outlined by CMS and applicable manufacturers and with EFPIA Disclosure Code reporting requirements.